Backed by decades of experience.
Solvonis Therapeutics is backed by an experienced team of pharmaceutical specialists and advocates for better ways to treat addiction, psychiatry and neurology disorders.
Boasting an extensive leadership team and a handpicked board of directors, Solvonis Therapeutics is well positioned to lead the development of novel, effective therapeutics.
CEO
Anthony Tennyson
Chief Scientific Advisor
Prof David Nutt
Chief Financial Officer
Ryan Neates
Leadership team
Chair
Dennis Purcell
CEO
Anthony Tennyson
Non-Executive Director
Dr. Renata Crome
Non-Executive Director
Paul Carter
Non-Executive Director
Nicholas Nelson
Board
Solvonis: towards freedom
Derived from the Latin root solv, meaning to release, unbind and free, and the suffix onis, meaning unity. Our name evokes an unshackling from debilitating mental health conditions, through novel, effective therapeutics. We aim to free patients from suffering and enable them to reconnect with their families and communities.